CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT00955916 · COMPLETED
Trial details
- NCT number
- NCT00955916
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2012-12-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.